Internal Medicine, Hematology & Oncology · Los Angeles, CA
NPI
1730102286
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1245 Wilshire Blvd, Suite 801
Los Angeles, CA, 90017
Phone (213) 481-3948
Groups this clinician bills Medicare through
Medicare paid, 2024
$731K
25,832 services
Medicare patients, 2024
208
Average age 73
Drug cost, 2024
$3.1M
947 prescriptions
Company payments, 2025
$3,554
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leo E Orr Jr. was code J0897 (injection, denosumab, 1 mg), 5,640 times for 26 patients. In total Leo E Orr Jr. billed 25,832 services in 66 codes, and Medicare paid $731K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,640 | 26 | $20.59 | $116K |
| 99214 Office E&M - Established | Office | 189 | 95 | $94.90 | $18K |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 162 | 26 | $92.74 | $15K |
| 36415 Venipuncture Blood Collection | Office | 136 | 78 | $8.65 | $1,176 |
| 96372 Injection Administration | Office | 133 | 34 | $11.69 | $1,554 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 90 | 19 | $0.63 | $56.42 |
| 99213 Office E&M - Established | Office | 81 | 71 | $67.42 | $5,461 |
| 96127 Behavioral Health Services | Office | 80 | 66 | $4.33 | $346 |
| 96413 Chemotherapy Administration | Office | 48 | 11 | $120.28 | $5,774 |
| 99232 Hospital E&M - Subsequent | Facility | 44 | 17 | $65.82 | $2,896 |
| 96367 Intravenous Infusion, Hydration | Office | 43 | 16 | $24.64 | $1,059 |
| 96365 Intravenous Infusion, Hydration | Office | 43 | 21 | $54.67 | $2,351 |
| 99215 Office E&M - Established | Office | 34 | 23 | $148.74 | $5,057 |
| 99212 Office E&M - Established | Office | 26 | 21 | $44.11 | $1,147 |
| 99223 Hospital E&M - Initial | Facility | 16 | 16 | $145.09 | $2,322 |
By year: 2022 $703K for 30,357 services; 2023 $703K for 30,272 services; 2024 $731K for 25,832 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 136 | 78 | $8.65 | $1,176 |
Medicare prescription drug claims, 2024
In 2024, the drug Leo E Orr Jr. prescribed most often to Medicare patients was Letrozole, with 83 prescriptions and refills. In total Leo E Orr Jr. wrote 947 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 83 | 144 | 19 | $1,323 |
| Anastrozole Generic | 50 | 128 | 16 | $1,173 |
| Xtandi Enzalutamide | 45 | 45 | Under 11 | $596K |
| Prednisone Generic | 39 | 44 | Under 11 | $171 |
| Ibrance Palbociclib | 29 | 29 | Under 11 | $447K |
| Verzenio Abemaciclib | 29 | 29 | Under 11 | $366K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 27 | 27 | 13 | $858 |
| Gabapentin Generic | 26 | 26 | Under 11 | $273 |
| Ondansetron Hcl Generic | 25 | 27 | 14 | $335 |
| Lactulose Generic | 24 | 26 | Under 11 | $202 |
| Revlimid Lenalidomide | 22 | 22 | Under 11 | $317K |
| Dexamethasone Generic | 21 | 21 | Under 11 | $312 |
| Tramadol Hcl Generic | 20 | 20 | Under 11 | $157 |
| Olanzapine Generic | 20 | 20 | 11 | $227 |
| Hydroxyurea Generic | 19 | 49 | Under 11 | $1,134 |
Brand drugs: 260 claims; generic drugs: 687 claims; opioid claims: 62.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leo E Orr Jr. $3,554 ($3,554 in general payments such as food, travel and fees) from 34 companies. The largest payer was Janssen Biotech, Inc. with $644.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 21 | $644 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $288 |
| Pfizer Inc. PFE | 10 | $255 |
| Incyte Corporation INCY | 8 | $203 |
| Celgene Corporation BMY | 11 | $184 |
| Astellas Pharma US Inc 4503.T | 6 | $183 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $177 |
| Abbvie Inc. ABBV | 6 | $144 |
| Daiichi Sankyo Inc. 4568.T | 7 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $107 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.